Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Ebinger

Showing results (191-200 of 258) with videos related to

Pageof 26
Sort By:
Stroke|October 31, 2019
Quantitative Signal Intensity in Fluid-Attenuated Inversion Recovery and Treatment Effect in the WAKE-UP TrialBastian Cheng, Florent Boutitie, Alina Nickel, et al.
British Journal of Haematology|December 6, 2017
CD34<sup>+</sup> selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantationChiara Mainardi, Martin Ebinger, Sigrid Enkel, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 21, 2017
Clinical characteristics of unknown symptom onset stroke patients with and without diffusion-weighted imaging and fluid-attenuated inversion recovery mismatchGötz Thomalla, Florent Boutitie, Jochen B Fiebach, et al.
Stroke|February 9, 2017
Stroke With Unknown Time of Symptom Onset: Baseline Clinical and Magnetic Resonance Imaging Data of the First Thousand Patients in WAKE-UP (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke: A Randomized, Doubleblind, Placebo-Controlled Trial)Götz Thomalla, Florent Boutitie, Jochen B Fiebach, et al.
The Lancet. Neurology|July 20, 2016
Functional outcomes of pre-hospital thrombolysis in a mobile stroke treatment unit compared with conventional care: an observational registry studyAlexander Kunz, Martin Ebinger, Frederik Geisler, et al.
Pediatric Blood & Cancer|August 4, 2021
Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumorsMona Steinbügl, Karolina Nemes, Pascal Johann, et al.
Cerebrovascular Diseases (Basel, Switzerland)|March 2, 2023
Predictors of Early Neurological Improvement and Its Relationship to Thrombolysis Treatment and Long-Term Outcome in the WAKE-UP StudyMarlene Heinze, Bastian Cheng, Tae-Hee Cho, et al.
Brain Communications|September 29, 2021
Game-theoretical mapping of fundamental brain functions based on lesion deficits in acute strokeCaroline Malherbe, Bastian Cheng, Alina Königsberg, et al.
Scientific Reports|June 30, 2021
Influence of stroke infarct location on quality of life assessed in a multivariate lesion-symptom mapping studyAlina Königsberg, Andrew T DeMarco, Carola Mayer, et al.
British Journal of Haematology|August 4, 2017
Neurotoxic side effects in children with refractory or relapsed T-cell malignancies treated with nelarabine based therapyMichaela Kuhlen, Kirsten Bleckmann, Anja Möricke, et al.
Pageof 26

Showing results (191-200 of 258) with videos related to

Sort By:
Pageof 26
Stroke|October 31, 2019
Quantitative Signal Intensity in Fluid-Attenuated Inversion Recovery and Treatment Effect in the WAKE-UP TrialBastian Cheng, Florent Boutitie, Alina Nickel, et al.
British Journal of Haematology|December 6, 2017
CD34<sup>+</sup> selected stem cell boosts can improve poor graft function after paediatric allogeneic stem cell transplantationChiara Mainardi, Martin Ebinger, Sigrid Enkel, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 21, 2017
Clinical characteristics of unknown symptom onset stroke patients with and without diffusion-weighted imaging and fluid-attenuated inversion recovery mismatchGötz Thomalla, Florent Boutitie, Jochen B Fiebach, et al.
Stroke|February 9, 2017
Stroke With Unknown Time of Symptom Onset: Baseline Clinical and Magnetic Resonance Imaging Data of the First Thousand Patients in WAKE-UP (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke: A Randomized, Doubleblind, Placebo-Controlled Trial)Götz Thomalla, Florent Boutitie, Jochen B Fiebach, et al.
The Lancet. Neurology|July 20, 2016
Functional outcomes of pre-hospital thrombolysis in a mobile stroke treatment unit compared with conventional care: an observational registry studyAlexander Kunz, Martin Ebinger, Frederik Geisler, et al.
Pediatric Blood & Cancer|August 4, 2021
Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumorsMona Steinbügl, Karolina Nemes, Pascal Johann, et al.
Cerebrovascular Diseases (Basel, Switzerland)|March 2, 2023
Predictors of Early Neurological Improvement and Its Relationship to Thrombolysis Treatment and Long-Term Outcome in the WAKE-UP StudyMarlene Heinze, Bastian Cheng, Tae-Hee Cho, et al.
Brain Communications|September 29, 2021
Game-theoretical mapping of fundamental brain functions based on lesion deficits in acute strokeCaroline Malherbe, Bastian Cheng, Alina Königsberg, et al.
Scientific Reports|June 30, 2021
Influence of stroke infarct location on quality of life assessed in a multivariate lesion-symptom mapping studyAlina Königsberg, Andrew T DeMarco, Carola Mayer, et al.
British Journal of Haematology|August 4, 2017
Neurotoxic side effects in children with refractory or relapsed T-cell malignancies treated with nelarabine based therapyMichaela Kuhlen, Kirsten Bleckmann, Anja Möricke, et al.
Pageof 26